Pub. Date : 2015 Feb 26
PMID : 25499760
1 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Despite major advances in the treatment of this highly aggressive disease with potent inhibitors of the BCR-ABL kinase such as dasatinib, patients in remission frequently relapse due to persistent minimal residual disease possibly supported, at least in part, by salutary cytokine-driven signaling within the hematopoietic microenvironment. | Dasatinib | ABL proto-oncogene 1, non-receptor tyrosine kinase | Homo sapiens |